Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie E Powell

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The Lancet. Oncology|April 13, 2023
Endometrial cancer: the individual approachMelanie E Powell
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 8, 2022
The role of radiotherapy in ovarian cancerKimberley Durno, Melanie E Powell
The British Journal of Radiology|April 21, 2021
PARP inhibitors and immunotherapy in ovarian and endometrial cancersRowan E Miller, Amy J Lewis, Melanie E Powell
The Lancet. Oncology|May 5, 2018
Investigators' responseRemi A Nout, Melanie E Powell, Stephanie M de Boer, et al.
Lancet (London, England)|April 10, 2022
Endometrial cancerEmma J Crosbie, Sarah J Kitson, Jessica N McAlpine, et al.
Psycho-Oncology|October 23, 2024
Psychometric Evaluation of the Cancer Dependent Quality of Life (CancerDQoL) Questionnaire: An Individualised Measure of the Impact of Cancer and Its Treatment on Quality of LifeJonathan Davidson, Michelle D Taylor, Charlie J Gilbride, et al.
Cancers|December 30, 2020
HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical OutcomesLisa Vermij, Nanda Horeweg, Alicia Leon-Castillo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 3, 2016
Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studiesSarah Kitson, Vanitha N Sivalingam, James Bolton, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancerInge C Van Gool, Ellen Stelloo, Remi A Nout, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2015
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiativeEllen Stelloo, Tjalling Bosse, Remi A Nout, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The Lancet. Oncology|April 13, 2023
Endometrial cancer: the individual approachMelanie E Powell
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 8, 2022
The role of radiotherapy in ovarian cancerKimberley Durno, Melanie E Powell
The British Journal of Radiology|April 21, 2021
PARP inhibitors and immunotherapy in ovarian and endometrial cancersRowan E Miller, Amy J Lewis, Melanie E Powell
The Lancet. Oncology|May 5, 2018
Investigators' responseRemi A Nout, Melanie E Powell, Stephanie M de Boer, et al.
Lancet (London, England)|April 10, 2022
Endometrial cancerEmma J Crosbie, Sarah J Kitson, Jessica N McAlpine, et al.
Psycho-Oncology|October 23, 2024
Psychometric Evaluation of the Cancer Dependent Quality of Life (CancerDQoL) Questionnaire: An Individualised Measure of the Impact of Cancer and Its Treatment on Quality of LifeJonathan Davidson, Michelle D Taylor, Charlie J Gilbride, et al.
Cancers|December 30, 2020
HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical OutcomesLisa Vermij, Nanda Horeweg, Alicia Leon-Castillo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 3, 2016
Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studiesSarah Kitson, Vanitha N Sivalingam, James Bolton, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancerInge C Van Gool, Ellen Stelloo, Remi A Nout, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2015
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiativeEllen Stelloo, Tjalling Bosse, Remi A Nout, et al.
Pageof 3